[1] |
MILLIER A, SCHMIDT U, ANGERMEYER MC, et al.Humanistic burden in schizophrenia:a literature review[J].J Psychiatr Res, 2014, 54:85. doi: 10.1016/j.jpsychires.2014.03.021 |
[2] |
RIPKE S, NEALE BM, CORVIN A, et al.Biological insights from 108 schizophrenia-associated genetic loci[J].Nature, 2014, 511(7510):421. doi: 10.1038/nature13595 |
[3] |
CAI Y, YU X, HU S, et al.A brief review on the mechanisms of miRNA regulation[J].Genomics Proteomics Bioinformatics, 2009, 7(4):147. doi: 10.1016/S1672-0229(08)60044-3 |
[4] |
SUN XY, ZHANG J, NIU W, et al.A preliminary analysis of microRNA as potential clinical biomarker for schizophrenia[J].Am J Med Genet B Neuropsychiatr Genet, 2015, 168B(3):170. |
[5] |
KARAGKOUNI D, PARASKEVOPOULOU MD, CHATZOPOULOS S, et al.DIANA-TarBase v8:a decade-long collection of experimentally supported miRNA-gene interactions[J].Nucleic Acids Res, 2018, 46(D1):D239. doi: 10.1093/nar/gkx1141 |
[6] |
VLACHOS IS, ZAGGANAS K, PARASKEVOPOULOU MD, et al.DIANA-miRPath v3.0:deciphering microRNA function with experimental support[J].Nucleic Acids Res, 2015, 43(W1):W460. doi: 10.1093/nar/gkv403 |
[7] |
GEORGAKILAS G, VLACHOS IS, ZAGGANAS K, et al.DIANA-miRGen v3.0:accurate characterization of microRNA promoters and their regulators[J].Nucleic Acids Res, 2015, 44(D1):D190. |
[8] |
FRIEDMAN RC, FARH KKH, BURGE CB, et al.Most mammalian mRNAs are conserved targets of microRNAs[J].Genome Res, 2009, 19(1):92. |
[9] |
HAUBERG ME, ROUSSOS P, GROVE J, et al.Analyzing the role of microRNAs in schizophrenia in the context of common genetic risk variants[J].JAMA Psychiatry, 2016, 73(4):369. doi: 10.1001/jamapsychiatry.2015.3018 |
[10] |
SONG HT, SUN XY, ZHANG L, et al.A preliminary analysis of association between the down-regulation of microRNA-181b expression and symptomatology improvement in schizophrenia patients before and after antipsychotic treatment[J].J Psychiatr Res, 2014, 54:134. doi: 10.1016/j.jpsychires.2014.03.008 |
[11] |
FERNÁNDEZ R, MALLO M, SOLÉ F, et al.15q13.3 microdeletion identified by High-density array in a Turner syndrome female with intellectual disability, significant language delay and autism[J].Sex Health, 2017, 1(1):1. |
[12] |
INOUE S, IMAMURA A, OKAZAKI Y, et al.Synaptotagmin XI as a candidate gene for susceptibility to schizophrenia[J].Am J Med Genet B Neuropsychiatr Genet, 2007, 144B(3):332. doi: 10.1002/(ISSN)1552-485X |
[13] |
LUO X, HUANG L, JIA P, et al.Protein-protein interaction and pathway analyses of top schizophrenia genes reveal schizophrenia susceptibility genes converge on common molecular networks and enrichment of nucleosome (chromatin) assembly genes in schizophrenia susceptibility loci[J].Schizophr Bull, 2013, 40(1):39. |
[14] |
CATTANE N, MINELLI A, MILANESI E, et al.Altered gene expression in schizophrenia:findings from transcriptional signatures in fibroblasts and blood[J].PLoS One, 2015, 10(2):e0116686. doi: 10.1371/journal.pone.0116686 |
[15] |
PÉREZ-SANTIAGO J, DIEZ-ALARCIA R, CALLADO LF, et al.A combined analysis of microarray gene expression studies of the human prefrontal cortex identifies genes implicated in schizophrenia[J].J Psychiatr Res, 2012, 46(11):1464. doi: 10.1016/j.jpsychires.2012.08.005 |
[16] |
DUCLOT F, KABBAJ M.The role of early growth response 1(EGR1) in brain plasticity and neuropsychiatric disorders[J].Front Behav Neurosci, 2017, 11:35. |
[17] |
BARBOSA AC, KIM MS, ERTUNC M, et al.MEF2C, a transcription factor that facilitates learning and memory by negative regulation of synapse numbers and function[J].Proc Natl Acad Sci U S A, 2008, 105(27):9391. doi: 10.1073/pnas.0802679105 |
[18] |
MITCHELL AC, JAVIDFAR B, POTHULA V, et al.MEF2C transcription factor is associated with the genetic and epigenetic risk architecture of schizophrenia and improves cognition in mice[J].Mol Psychiatry, 2018, 23(1):123. doi: 10.1038/mp.2016.254 |